CSL Behring chief Paul Perreault scored an unusual coup last summer when he added AstraZeneca CEO Pascal Soriot to the board, via Zoom. It’s rare …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.